BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35124951)

  • 1. Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis.
    Ayoub F; Odenwald M; Micic D; Dalal SR; Pekow J; Cohen RD; Rubin DT; Sakuraba A
    Intest Res; 2022 Apr; 20(2):240-250. PubMed ID: 35124951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Medical Therapies for Fistulizing Crohn's Disease: Systematic Review and Meta-analysis.
    Lee MJ; Parker CE; Taylor SR; Guizzetti L; Feagan BG; Lobo AJ; Jairath V
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1879-1892. PubMed ID: 29374617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ustekinumab for active perianal fistulizing Crohn's disease: a systematic review and meta-analysis of the current literature.
    Attauabi M; Burisch J; Seidelin JB
    Scand J Gastroenterol; 2021 Jan; 56(1):53-58. PubMed ID: 33264569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Therapies for the Management of Fistulizing Crohn's Disease: A Systematic Review and Meta-Analysis.
    Vuyyuru SK; Solitano V; Narula N; Lee MJ; MacDonald JK; McCurdy JD; Singh S; Ma C; Jairath V
    J Crohns Colitis; 2024 Apr; 18(4):589-603. PubMed ID: 37933849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
    Tonelli F; Giudici F; Asteria CR
    Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
    Meima-van Praag EM; van Rijn KL; Wasmann KATGM; Snijder HJ; Stoker J; D'Haens GR; Gecse KB; Gerhards MF; Jansen JM; Dijkgraaf MGW; van der Bilt JDW; Mundt MW; Spinelli A; Danese S; Bemelman WA; Buskens CJ
    Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):617-626. PubMed ID: 35427495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of FiLaC™ for perianal fistulizing Crohn's disease: a systematic review and meta-analysis.
    Cao D; Li W; Ji Y; Wang X; Cui Z
    Tech Coloproctol; 2022 Oct; 26(10):775-781. PubMed ID: 35962294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous fat graft injections for the treatment of perianal fistulas in Crohn's disease: a systematic review and single-arm meta-analysis.
    De Gregorio M; Tiang T; Lee T; Stellingwerf ME; Singh S; Thompson AJ; D'Souza B; Ding NS;
    ANZ J Surg; 2023 May; 93(5):1162-1168. PubMed ID: 36658773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Drug Monitoring in Perianal Fistulizing Crohn's Disease.
    Zulqarnain M; Deepak P; Yarur AJ
    J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Therapy of Perianal Crohn's Disease.
    Klag T; Goetz M; Stange EF; Wehkamp J
    Viszeralmedizin; 2015 Aug; 31(4):265-72. PubMed ID: 26557835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
    Garcia-Olmo D; Gilaberte I; Binek M; D Hoore AJL; Lindner D; Selvaggi F; Spinelli A; Panés J
    Dis Colon Rectum; 2022 May; 65(5):713-720. PubMed ID: 34890373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remicade does not abolish the need for surgery in fistulizing Crohn's disease.
    Poritz LS; Rowe WA; Koltun WA
    Dis Colon Rectum; 2002 Jun; 45(6):771-5. PubMed ID: 12072629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Perianal Fistulizing Crohn's Disease.
    Singh A; Midha V; Kochhar GS; Shen B; Sood A
    Inflamm Bowel Dis; 2023 Sep; ():. PubMed ID: 37672347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn's Disease: ENTERPRISE Study.
    Schwartz DA; Peyrin-Biroulet L; Lasch K; Adsul S; Danese S
    Clin Gastroenterol Hepatol; 2022 May; 20(5):1059-1067.e9. PubMed ID: 34597729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children.
    El-Matary W; Walters TD; Huynh HQ; deBruyn J; Mack DR; Jacobson K; Sherlock ME; Church P; Wine E; Carroll MW; Benchimol EI; Lawrence S; Griffiths AM
    Inflamm Bowel Dis; 2019 Jan; 25(1):150-155. PubMed ID: 29912413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Neutrophil Extracellular Traps with Fistula Healing in Patients with Complex Perianal Fistulizing Crohn's Disease.
    Cao D; Qian K; Zhao Y; Hong J; Chen H; Wang X; Yang N; Zhang C; Cao J; Jia K; Wu G; Zhu M; Shen J; Zhang Y; Cui Z; Wang Z
    J Crohns Colitis; 2023 Apr; 17(4):580-592. PubMed ID: 36322703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
    Strik AS; Löwenberg M; Buskens CJ; B Gecse K; I Ponsioen C; Bemelman WA; D'Haens GR
    Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
    [No Abstract]   [Full Text] [Related]  

  • 20. Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients.
    Chapuis-Biron C; Bourrier A; Nachury M; Nancey S; Bouhnik Y; Serrero M; Armengol-Debeir L; Buisson A; Tran-Minh ML; Zallot C; Fumery M; Bouguen G; Abitbol V; Viennot S; Chanteloup E; Rajca S; Dib N; Parmentier AL; Peyrin-Biroulet L; Vuitton L;
    Aliment Pharmacol Ther; 2020 Apr; 51(7):719-727. PubMed ID: 32080886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.